Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
6.62 Down 0.40(5.70%) Sep 2, 3:59PM EDT
Add to Portfolio
Prev Close:7.02
Open:7.13
Bid:N/A
Ask:7.80 x 500
1y Target Est:9.00
Beta:0.776653
Earnings Date:Nov 4 - Nov 9 (Est.)
Day's Range:6.50 - 7.35
52wk Range:5.45 - 8.50
Volume:3,520,593
Avg Vol (3m):1,020,580
Market Cap:445.60M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:0.15 (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SPPIDown 5.70%445.60M
BIIBUp 4.00%71.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.51
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-15) :-0.90
Quarterly EPS Est (Sep-15) :-0.25
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, including FUSILEV for the treatment of patients with metastatic colorectal cancer, ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback